Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields.The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, physical medicine and rehabilitation, primary and urgent care rheumatology, and sports medicine.
Its products comprise The Wand, a computer-assisted system for local anesthesia; and CompuFlo Epidural instruments that uses pressure sensing technology, which provides an objective tool for medical professionals to consistently and accurately identify the epidural space.The company’s products are used in the therapeutic areas of colorectal surgery, podiatry, dermatology, nasal and sinus surgery, hair transplantation and plastic surgery.
Milestone Scientific is headquartered in New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Milestone Scientific Inc - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
588 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- The global market for Hydrogel is projected to reach US$15.3 billion by 2025, driven by their growing use in wound care products and drug delivery systems (DDS). Defined as a three-dimensional (3D) hydrophilic polymer capable of holding large amounts of water, hydrogel is valuable in biological applications...
Advanced Drug Delivery Systems Market Report Overview Advanced Drug Delivery Systems market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Advanced Drug Delivery Systems market types and applications. It is a focused study on Advanced Drug...
The Global Nanosilica Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing investments in R&D globally, increase in the demand for nanosilica for use in nanocoatings, and growing...
307 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period...
145 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Nanotechnology in Drug Delivery Market to Reach $164.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Nanotechnology in Drug Delivery estimated at US$47.5 Billion in the year 2020, is projected to reach a revised size of US$164.1 Billion by 2027, growing at aCAGR of 19.4% over...
112 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Novel Drug Delivery Systems (NDDS) Market to Reach $27.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$7.7 Billion in the year 2020, is projected to reach a revised size of US$27.2 Billion by 2027, growing at aCAGR of 19.7% over...
170 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Connected Drug Delivery Devices Market to Reach $1.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Connected Drug Delivery Devices estimated at US$166.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at aCAGR of 36.4% over the...
294 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Controlled Release Drug Delivery Market to Reach $57.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Controlled Release Drug Delivery estimated at US$36.7 Billion in the year 2020, is projected to reach a revised size of US$57.3 Billion by 2027, growing at a CAGR of 6.6% over...
286 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Electronic Drug Delivery Systems Market to Reach $13.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Electronic Drug Delivery Systems estimated at US$8.2 Billion in the year 2020, is projected to reach a revised size of US$13.8 Billion by 2027, growing at a CAGR of 7.6% over...
Market Overview: The global chitosan market reached a value of US$ 2.49 Billion in 2020. Chitosan is a naturally occurring deacetylated chitin which is extracted from the hard outer-skeleton or shells of shrimps, crabs and lobsters, along with mushrooms and yeasts. It is primarily used as an ingredient in medicines...
Pharmaceutical
Drug Delivery
Water Treatment
World
Pharmaceutical Production
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.